1. Academic Validation
  2. 1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus

1,6-Bis[(benzyloxy)methyl]uracil derivatives-Novel antivirals with activity against HIV-1 and influenza H1N1 virus

  • Bioorg Med Chem. 2016 Jun 1;24(11):2476-2485. doi: 10.1016/j.bmc.2016.04.010.
Alexander N Geisman 1 Vladimir T Valuev-Elliston 2 Alexander A Ozerov 1 Anastasia L Khandazhinskaya 2 Alexander O Chizhov 3 Sergey N Kochetkov 2 Christophe Pannecouque 4 Lieve Naesens 4 Katherine L Seley-Radtke 5 Mikhail S Novikov 1
Affiliations

Affiliations

  • 1 Department of Pharmaceutical & Toxicological Chemistry, Volgograd State Medical University, Pavshikh Bortsov Sq., 1, Volgograd 400131, Russia.
  • 2 Engelhardt Institute of Molecular Biology, Russian Academy of Science, Vavilov Str., 32, Moscow 119991, Russia.
  • 3 Zelinsky Institute of Organic Chemistry, Russian Academy of Science, Leninsky pr., 47, Moscow 119991, Russia.
  • 4 KU Leuven, Department of Microbiology and Immunology, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
  • 5 Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA. Electronic address: kseley@umbc.edu.
Abstract

A series of 1,6-bis[(benzyloxy)methyl]uracil derivatives combining structural features of both diphenyl ether and pyridone types of NNRTIs were synthesized. Target compounds were found to inhibit HIV-1 Reverse Transcriptase at micro- and submicromolar levels of concentrations and exhibited anti-HIV-1 activity in MT-4 Cell Culture, demonstrating resistance profile similar to first generation NNRTIs. The synthesized compounds also showed profound activity against Influenza Virus (H1N1) in MDCK Cell Culture without detectable cytotoxicity. The lead compound of this assay appeared to exceed rimantadine, amantadine, ribavirin and oseltamivir carboxylate in activity. The mechanism of action of 1,6-bis[(benzyloxy)methyl]uracils against Influenza Virus is currently under investigation.

Keywords

HIV; Influenza virus; NNRTIs; Non-nucleoside reverse transcriptase inhibitors; Uracil.

Figures